These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26280117)

  • 1. Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From the Simvastatin in Aneurysmal Subarachnoid Hemorrhage (STASH) Trial.
    Turner CL; Budohoski K; Smith C; Hutchinson PJ; Kirkpatrick PJ; Murray GD;
    Neurosurgery; 2015 Nov; 77(5):786-92; discussion 792-3. PubMed ID: 26280117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage - Serum D-dimer and C-reactive Protein as Early Markers.
    Hurth H; Birkenhauer U; Steiner J; Schlak D; Hennersdorf F; Ebner FH
    J Stroke Cerebrovasc Dis; 2020 Mar; 29(3):104558. PubMed ID: 31889655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH Analysis.
    Teo M; Guilfoyle MR; Turner C; Kirkpatrick PJ;
    World Neurosurg; 2017 Sep; 105():270-281. PubMed ID: 28502692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial.
    Kirkpatrick PJ; Turner CL; Smith C; Hutchinson PJ; Murray GD;
    Lancet Neurol; 2014 Jul; 13(7):666-75. PubMed ID: 24837690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial inflammatory response is an independent predictor of unfavorable outcome in patients with good-grade aneurysmal subarachnoid hemorrhage.
    Güresir E; Coch C; Fimmers R; Ilic I; Hadjiathanasiou A; Kern T; Brandecker S; Güresir Á; Velten M; Vatter H; Schuss P
    J Crit Care; 2020 Dec; 60():45-49. PubMed ID: 32739759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhage.
    Pan JW; He LN; Xiao F; Shen J; Zhan RY
    Crit Care; 2013 Jul; 17(4):R149. PubMed ID: 23880145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute-Phase Plasma Osteopontin as an Independent Predictor for Poor Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Nakatsuka Y; Shiba M; Nishikawa H; Terashima M; Kawakita F; Fujimoto M; Suzuki H;
    Mol Neurobiol; 2018 Aug; 55(8):6841-6849. PubMed ID: 29353454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.
    Abboud T; Mende KC; Jung R; Czorlich P; Vettorazzi E; Priefler M; Kluge S; Westphal M; Regelsberger J
    World Neurosurg; 2017 Dec; 108():669-675. PubMed ID: 28943424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low neurologic intensive care unit hemoglobin as a predictor for intra-arterial vasospasm therapy and poor discharge modified Rankin Scale in aneurysmal subarachnoid haemorrhage-induced cerebral vasospasm.
    Bell DL; Kimberly WT; Yoo AJ; Leslie-Mazwi TM; Rabinov JD; Bell JE; Mehta BP; Hirsch JA
    J Neurointerv Surg; 2015 Jun; 7(6):438-42. PubMed ID: 24814068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma visfatin, a possible prognostic marker in aneurysmal subarachnoid hemorrhage.
    Wang JX; Hou Y; Ruan SP; Wang J; Hu XM
    Peptides; 2013 Dec; 50():8-12. PubMed ID: 24120704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage.
    Mack WJ; Mocco J; Hoh DJ; Huang J; Choudhri TF; Kreiter KT; Lozier A; Opperman M; Poisik A; Yorgason J; Solomon RA; Mayer SA; Connolly ES
    J Neurosurg; 2002 Jan; 96(1):71-5. PubMed ID: 11794607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma copeptin and multiple biomarkers for assessing prognosis of patients with aneurysmal subarachnoid hemorrhage.
    Zheng YK; Dong XQ; Du Q; Wang H; Yang DB; Zhu Q; Che ZH; Shen YF; Jiang L; Hu W; Wang KY; Yu WH
    Clin Chim Acta; 2017 Dec; 475():64-69. PubMed ID: 29037840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma D-dimer may predict poor functional outcomes through systemic complications after aneurysmal subarachnoid hemorrhage.
    Fukuda H; Lo B; Yamamoto Y; Handa A; Yamamoto Y; Kurosaki Y; Yamagata S
    J Neurosurg; 2017 Aug; 127(2):284-290. PubMed ID: 27518526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated C-reactive protein and white blood cell count at admission predict functional outcome after non-aneurysmal subarachnoid hemorrhage.
    Schuss P; Hadjiathanasiou A; Brandecker S; Güresir Á; Vatter H; Güresir E
    J Neurol; 2018 Dec; 265(12):2944-2948. PubMed ID: 30317466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.
    Giede-Jeppe A; Reichl J; Sprügel MI; Lücking H; Hoelter P; Eyüpoglu IY; Kuramatsu JB; Huttner HB; Gerner ST
    J Neurosurg; 2019 Feb; 132(2):400-407. PubMed ID: 30717052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
    Liu H; Xu X
    Am J Emerg Med; 2017 Dec; 35(12):1940-1945. PubMed ID: 28966073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum glucose/potassium ratio as a clinical risk factor for aneurysmal subarachnoid hemorrhage.
    Fujiki Y; Matano F; Mizunari T; Murai Y; Tateyama K; Koketsu K; Kubota A; Kobayashi S; Yokota H; Morita A
    J Neurosurg; 2018 Oct; 129(4):870-875. PubMed ID: 29148905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage.
    Sanchez-Peña P; Pereira AR; Sourour NA; Biondi A; Lejean L; Colonne C; Boch AL; Al Hawari M; Abdennour L; Puybasset L
    Crit Care Med; 2008 Aug; 36(8):2267-73. PubMed ID: 18596638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of plasma soluble CD40 ligand levels following aneurysmal subarachnoid hemorrhage.
    Chen XD; Sun J; Lu C; Ba HJ; Chen MH; Lin JH; Cai JY
    Thromb Res; 2015 Jul; 136(1):24-9. PubMed ID: 25944664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.